Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

By sjmartinez • May 26, 2023

Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023 May 25:ciad319. doi: 10.1093/cid/ciad319. Epub ahead of print. PMID: 37229695.

Tags: Direct-acting antivirals, HCV guidance, HCV prevention, HCV screening, HCV treatment, Infectious Diseases, Publications

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureusBacteremia

Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, Ruffin F, Fowler VG Jr,[...]

Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083

Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement[...]

Immune activation from M. tuberculosis screening tests predicts mortality

Seligman B, Ganz DA, Goetz MB, Beenhouwer DO. Immune activation from M. tuberculosis screening tests predicts mortality. Geroscience. 2026 Apr 27. doi: 10.1007/s11357-026-02221-y. Epub ahead[...]